Acquisitions

BioMarin to Acquire Alesta

Rare disease maven bets on a next generation bone-forming medicine

Aug 18 • Céline

Jazz to Acquire Actio

How David Goldstein's precision neuroscience thesis hit escape velocity

Aug 10 • Céline

AstraZeneca-BMS Merger Cancelled

Exploring the Pax Pharmaceutica that never arrived

Aug 8 • Céline

Argenx to Acquire Forte Biosciences

How Paul Wagner's pivot from microbiome medicines to CD122 for celiac and vitiligo paid off

Jul 27 • Céline

Eli Lilly to Acquire AtaiBeckley

SSRI/SNRI powerhouse bets on neuroplasticity for depression

Jul 17 • Céline

Vertex to Acquire Crinetics

How R. Scott Struthers and his crew from Neurocrine went out on their own and struck gold in rare metabolic disease

Jul 7 • Céline

Novartis to Acquire Myricx Bio

Another preclinical ADC payload company exits north of a billion dollars

Jul 6 • Céline

United Therapeutics to Acquire Thymmune

Regenerative medicine titans join forces to grow a thymus

Jul 2 • Céline

Ipsen to Acquire Memo

Neutralizing the viral ghosts that haunt kidney transplant patients

Jul 1 • Céline

Zymeworks to Acquire Theravance

M&A alchemy with a COPD sweetener

Jul 1 • Céline

Ipsen to Acquire Kartos

Unleashing apoptotic p53 on myelofibrosis

Jun 30 • Céline

AbbVie to Acquire Apogee

Paragon's long-acting atopic dermatitis & asthma pipeline pays off

Jun 23 • Céline

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts